CUPR

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index	-	P/E	-	EPS (ttm)	-0.05	Insider Own	65.66%	Shs Outstand	7.37M	Perf Week	107.14%
Market Cap	31.10M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.37M	Perf Month	-84.26%
Enterprise Value	31.20M	PEG	-	EPS next Q	-	Inst Own	0.57%	Short Float	3.24%	Perf Quarter	-74.52%
Income	-1.17M	P/S	777.56	EPS this Y	-	Inst Trans	0.12%	Short Ratio	0.10	Perf Half Y	-
Sales	0.04M	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.24M	Perf YTD	-65.06%
Book/sh	-0.15	P/C	345.58	EPS next 5Y	-	ROE	-	52W High	9.50 -84.74%	Perf Year	-
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	-45.12% -	ROIC	-	52W Low	0.61 137.24%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-6.00% -	Gross Margin	-72.91%	Volatility	38.20% 70.32%	Perf 5Y	-
Dividend TTM	-	EV/Sales	780.06	EPS Y/Y TTM	-	Oper. Margin	-3424.91%	ATR (14)	0.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.06	Sales Y/Y TTM	-	Profit Margin	-3249.92%	RSI (14)	36.24	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.06	EPS Q/Q	-	SMA20	43.84%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-71.67%	Rel Volume	0.79	Prev Close	1.31
Employees	14	LT Debt/Eq	-	Earnings	-	SMA200	-71.64%	Avg Volume	2.43M	Price	1.45
IPO	Apr 10, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	1,928,466	Change	10.69%

Sep-09-25 08:05AM	Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology (GlobeNewswire) +12.23%
Aug-18-25 08:00AM	Cuprina Reaffirms Commitment to Shareholders and Patients Following Recent Stock Market Activity (GlobeNewswire) +9.24%
Jul-21-25 09:00AM	Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market (GlobeNewswire) +5.02%
Jun-30-25 08:00AM	Cuprina Provides Update on Research Studies with Three Leading Education Institutes (GlobeNewswire)
Jun-04-25 08:00AM	Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries (GlobeNewswire)
01:05PM	Loading…
May-08-25 01:05PM	Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering (GlobeNewswire) -7.17%
May-06-25 10:45AM	Cuprina Holdings obtains dealer license for IVF media production facility (TipRanks) +5.38%
May-05-25 12:29PM	Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd. (GlobeNewswire) -9.87%
12:27PM	Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering (GlobeNewswire)
12:24PM	Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering (GlobeNewswire)
Apr-12-25 01:30AM	U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility (Seeking Alpha)
Apr-11-25 11:07AM	Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering (GlobeNewswire) +7.95%
Apr-10-25 08:35AM	Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering (GlobeNewswire)

Cuprina Holdings (Cayman) Ltd. engages in the manufacturing, sale, and supply of medical devices to manage and accelerate healing and closure of chronic wounds. Its products include nature-based bioactive, in the form of advanced wound dressings, derived from sustainable sources. The company was founded by Carl Marc Baptista on August 28, 2019 and is headquartered in Singapore.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Cuprina Holdings (Cayman) Ltd

Upgrade your FINVIZ experience